{"id":"https://openalex.org/W2000368348","doi":"https://doi.org/10.1371/journal.pone.0058575","title":"Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319","display_name":"Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319","publication_year":2013,"publication_date":"2013-03-11","ids":{"openalex":"https://openalex.org/W2000368348","doi":"https://doi.org/10.1371/journal.pone.0058575","mag":"2000368348","pmid":"https://pubmed.ncbi.nlm.nih.gov/23536797","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3594191"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0058575","doi":"https://doi.org/10.1371/journal.pone.0058575","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0058575","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0058575&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000368348"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0058575&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068454785","display_name":"Alexei Kharitonenkov","orcid":"https://orcid.org/0000-0001-6192-6606","observed_orcids":["https://orcid.org/0000-0001-6192-6606"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexei Kharitonenkov","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America. a.kharch@lilly.com","Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America. a.kharch@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109272191","display_name":"John M. Beals","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Beals","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029794052","display_name":"Radmila Micanovic","orcid":"https://orcid.org/0000-0002-8151-0234","observed_orcids":["https://orcid.org/0000-0002-8151-0234"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radmila Micanovic","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059233739","display_name":"Beth A. Strifler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth A. Strifler","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075074986","display_name":"Radhakrishnan Rathnachalam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radhakrishnan Rathnachalam","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014574719","display_name":"Victor J. Wroblewski","orcid":"https://orcid.org/0000-0002-0593-4350","observed_orcids":["https://orcid.org/0000-0002-0593-4350"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor J. Wroblewski","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100442633","display_name":"Shun Li","orcid":"https://orcid.org/0000-0002-3629-9900","observed_orcids":["https://orcid.org/0000-0002-3629-9900"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shun Li","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110290841","display_name":"Anja K\u00f6ester","orcid":"https://orcid.org/0009-0004-3142-9675","observed_orcids":["https://orcid.org/0009-0004-3142-9675"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anja Koester","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091171897","display_name":"Amy M. Ford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy M. Ford","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054260296","display_name":"Tamer Co\u015fkun","orcid":"https://orcid.org/0000-0002-2481-133X","observed_orcids":["https://orcid.org/0000-0002-2481-133X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamer Coskun","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088118453","display_name":"James D. Dunbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Dunbar","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966454","display_name":"Christine Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine C. Cheng","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110908447","display_name":"Christopher C. Frye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher C. Frye","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013934499","display_name":"Thomas F. Bumol","orcid":"https://orcid.org/0000-0003-4319-1006","observed_orcids":["https://orcid.org/0000-0003-4319-1006"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas F. Bumol","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082280074","display_name":"David E. Moller","orcid":"https://orcid.org/0000-0003-4366-4678","observed_orcids":["https://orcid.org/0000-0003-4366-4678"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Moller","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, United States of America","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068454785"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":5.2427,"has_fulltext":true,"cited_by_count":170,"citation_normalized_percentile":{"value":0.97325095,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"8","issue":"3","first_page":"e58575","last_page":"e58575"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf21","display_name":"FGF21","score":0.9860000014305115},{"id":"https://openalex.org/keywords/recombinant-protein-engineering","display_name":"recombinant protein engineering","score":0.7549999952316284},{"id":"https://openalex.org/keywords/n-terminal-deletion","display_name":"N-terminal deletion","score":0.5379999876022339},{"id":"https://openalex.org/keywords/pichia-pastoris-expression-system","display_name":"Pichia pastoris expression","score":0.9729999899864197},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.6269999742507935},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5820000171661377},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9440000057220459},{"id":"https://openalex.org/keywords/blood-glucose-reduction","display_name":"blood glucose reduction","score":0.5910000205039978},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6520000100135803},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.4050000011920929}],"concepts":[{"id":"https://openalex.org/C106646824","wikidata":"https://www.wikidata.org/wiki/Q5425475","display_name":"FGF21","level":4,"score":0.9537820816040039},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.6828447580337524},{"id":"https://openalex.org/C2781372317","wikidata":"https://www.wikidata.org/wiki/Q148697","display_name":"Pichia pastoris","level":4,"score":0.5255450010299683},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.46015551686286926},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40872520208358765},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.342669278383255},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.32724741101264954},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.2750226855278015},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.13297119736671448},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.13108986616134644},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000090265","descriptor_name":"Klotho Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010843","descriptor_name":"Pichia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010843","descriptor_name":"Pichia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013696","descriptor_name":"Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014644","descriptor_name":"Genetic Variation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016475","descriptor_name":"3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055550","descriptor_name":"Protein Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1371/journal.pone.0058575","doi":"https://doi.org/10.1371/journal.pone.0058575","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0058575","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0058575&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2605329","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3594191","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23536797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23536797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3594191","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3594191/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.785.4748","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.785.4748","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/ce/39/pone.0058575.PMC3594191.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:5847a90134ee450d8853ad80dc8fbeb7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5847a90134ee450d8853ad80dc8fbeb7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 8, Iss 3, p e58575 (2013)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0058575","doi":"https://doi.org/10.1371/journal.pone.0058575","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0058575","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0058575&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000368348.pdf","grobid_xml":"https://content.openalex.org/works/W2000368348.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W171195488","https://openalex.org/W310137578","https://openalex.org/W1497291976","https://openalex.org/W1572335436","https://openalex.org/W1943524962","https://openalex.org/W1979759104","https://openalex.org/W1989584881","https://openalex.org/W1999249055","https://openalex.org/W2000665430","https://openalex.org/W2012557883","https://openalex.org/W2028880837","https://openalex.org/W2050259739","https://openalex.org/W2050866090","https://openalex.org/W2068504772","https://openalex.org/W2070642362","https://openalex.org/W2073909738","https://openalex.org/W2074337024","https://openalex.org/W2076037986","https://openalex.org/W2079132151","https://openalex.org/W2086624706","https://openalex.org/W2089817491","https://openalex.org/W2091948921","https://openalex.org/W2094943792","https://openalex.org/W2110534048","https://openalex.org/W2111653877","https://openalex.org/W2114650931","https://openalex.org/W2119351413","https://openalex.org/W2122508875","https://openalex.org/W2124157676","https://openalex.org/W2130700195","https://openalex.org/W2145044799","https://openalex.org/W2146030191","https://openalex.org/W2155010729","https://openalex.org/W2168118376","https://openalex.org/W2410752599","https://openalex.org/W6714442369"],"related_works":["https://openalex.org/W2611434197","https://openalex.org/W1972717747","https://openalex.org/W2062842771","https://openalex.org/W2061512091","https://openalex.org/W2027618162","https://openalex.org/W2003495422","https://openalex.org/W1989618690","https://openalex.org/W3047314584"],"abstract_inverted_index":{"Fibroblast":[0],"growth":[1],"factor":[2],"21":[3],"is":[4,56],"a":[5,14,54,81,91,96,101,147,181,219,227,246],"novel":[6,82],"hormonal":[7],"regulator":[8],"with":[9,95,226],"the":[10,76,88,124,237,252],"potential":[11,92],"to":[12,40,66,134,139,166,200,250],"treat":[13],"broad":[15],"variety":[16],"of":[17,51,61,80,90,163,175,183,195,205,222,245,256],"metabolic":[18,42,265],"abnormalities,":[19],"such":[20],"as":[21,53],"type":[22,34],"2":[23],"diabetes,":[24],"obesity,":[25],"hepatic":[26],"steatosis,":[27],"and":[28,46,58,70,78,115,186,209,239],"cardiovascular":[29],"disease.":[30],"Human":[31],"recombinant":[32],"wild":[33],"FGF21":[35,52,83,112,118,164,258],"(FGF21)":[36],"has":[37],"been":[38],"shown":[39],"ameliorate":[41],"disorders":[43],"in":[44,100,111,145,158,169,180,184,187,207,218,230,261,267],"rodents":[45],"non-human":[47],"primates.":[48],"However,":[49],"development":[50,89],"drug":[55,93],"challenging":[57],"requires":[59],"re-engineering":[60,162],"its":[62,170],"amino":[63,127],"acid":[64],"sequence":[65],"improve":[67],"protein":[68,156],"expression":[69],"formulation":[71],"stability.":[72],"Here":[73],"we":[74],"report":[75],"design":[77],"characterization":[79],"variant,":[84],"LY2405319.":[85],"To":[86],"enable":[87],"product":[94],"once-daily":[97],"dosing":[98],"profile,":[99],"preserved,":[102],"multi-use":[103],"formulation,":[104],"an":[105,141],"additional":[106],"disulfide":[107],"bond":[108],"was":[109,119,132,150,178],"introduced":[110],"through":[113],"Leu118Cys":[114],"Ala134Cys":[116],"mutations.":[117],"further":[120],"optimized":[121],"by":[122],"deleting":[123],"four":[125],"N-terminal":[126],"acids,":[128],"His-Pro-Ile-Pro":[129],"(HPIP),":[130],"which":[131,190],"subject":[133],"proteolytic":[135],"cleavage.":[136],"In":[137],"addition,":[138],"eliminate":[140],"O-linked":[142],"glycosylation":[143],"site":[144],"yeast":[146],"Ser167Ala":[148],"mutation":[149],"introduced,":[151],"thus":[152],"allowing":[153],"large-scale,":[154],"homogenous":[155],"production":[157],"Pichia":[159],"pastoris.":[160],"Altogether":[161],"led":[165],"significant":[167],"improvements":[168],"biopharmaceutical":[171,238],"properties.":[172],"The":[173],"impact":[174],"these":[176],"changes":[177],"assessed":[179],"panel":[182],"vitro":[185],"vivo":[188],"assays,":[189],"confirmed":[191],"that":[192,254],"biological":[193,240],"properties":[194,241],"LY2405319":[196,206,234],"were":[197],"essentially":[198],"identical":[199],"FGF21.":[201],"Specifically,":[202],"subcutaneous":[203],"administration":[204,255],"ob/ob":[208],"diet-induced":[210],"obese":[211],"(DIO)":[212],"mice":[213],"over":[214],"7-14":[215],"days":[216],"resulted":[217],"25-50%":[220],"lowering":[221],"plasma":[223],"glucose":[224],"coupled":[225],"10-30%":[228],"reduction":[229],"body":[231],"weight.":[232],"Thus,":[233],"exhibited":[235],"all":[236],"required":[242],"for":[243],"initiation":[244],"clinical":[247],"program":[248],"designed":[249],"test":[251],"hypothesis":[253],"exogenous":[257],"would":[259],"result":[260],"effects":[262],"on":[263],"disease-related":[264],"parameters":[266],"humans.":[268]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}